KC
Therapeutic Areas
SeaStar Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Quelimmune (SCD) | Pediatric Acute Kidney Injury (AKI) with sepsis/septic condition | Approved |
| SCD (Adult) | Adult Acute Kidney Injury (AKI) requiring CRRT | Pivotal Trial |
| SCD (Pediatric) | Systemic Inflammatory Response in Cardiac Surgery (Pediatric) | Investigational |
Leadership Team at SeaStar Medical
ES
Eric Schlorff
Chief Executive Officer
MM
Michael Messinger
Chief Financial Officer
SP
Sai P. Iyer, Ph.D.
Senior Vice President, Medical Affairs & Research
TM
Tom Mullen
Vice President, Operations & Product Development
TV
Tim Varacek
Senior Vice President, Commercial & Business Operations
HD
H. David Humes, M.D.
SCD Inventor & Scientific Advisor
AA
Ayse Akcan-Arikan, MD
Scientific Advisor
DA
David Askenazi, MD, MSPH
Scientific Advisor
SB
Sean Bagshaw, MD, MSc
Scientific Advisor